These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1964731)

  • 1. Morphology of male breast carcinoma in the evaluation of prognosis.
    Cunha F; André S; Soares J
    Pathol Res Pract; 1990 Dec; 186(6):745-50. PubMed ID: 1964731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological grading of breast cancer. Interobserver, reproducibility and prognostic significance.
    Theissig F; Kunze KD; Haroske G; Meyer W
    Pathol Res Pract; 1990 Dec; 186(6):732-6. PubMed ID: 1964730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoma of male breast--with special reference to noninvasive carcinoma].
    Tahara H; Koyama H; Noguchi S; Nishizawa Y; Iwanaga T; Iijima S; Hatanaka T; Ohtsuru M; Kuriyama H; Higashiyama N
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):585-91. PubMed ID: 2549134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast cancer in men].
    Alexander LL; Benninghoff DL; Camiel MR; Solisio EO; Medina A
    Rev Interam Radiol; 1979 Jan; 4(1):21-7. PubMed ID: 232766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature].
    Denoux Y; Marnay J; Crouet H; Boute V; Delozier T; Vie B; Chasle J
    Bull Cancer; 2001 Apr; 88(4):419-25. PubMed ID: 11371378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
    Amat S; Penault-Llorca F; Cure H; Le Bouedëc G; Achard JL; Van Praagh I; Feillel V; Mouret-Reynier MA; Dauplat J; Chollet P
    Int J Oncol; 2002 Apr; 20(4):791-6. PubMed ID: 11894126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression.
    Logullo AF; Nonogaki S; Pasini FS; Osório CA; Soares FA; Brentani MM
    Oncol Rep; 2010 Feb; 23(2):313-20. PubMed ID: 20043090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases].
    Hauser H; Beham A; Steindorfer P; Smola MG; Fruhwirth H; Klimpfinger M
    Wien Klin Wochenschr; 1992; 104(23):717-20. PubMed ID: 1335634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The routine immunohistochemical evaluation in Paget disease of the nipple.
    Marczyk E; Kruczak A; Ambicka A; Mularz K; Harazin-Lechowska A; Moskal J; Sokołowski A; Mituś J; Ryś J
    Pol J Pathol; 2011 Dec; 62(4):229-35. PubMed ID: 22246908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.
    Domagala W; Lasota J; Dukowicz A; Markiewski M; Striker G; Weber K; Osborn M
    Am J Pathol; 1990 Dec; 137(6):1299-304. PubMed ID: 1701960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a basal-like subtype of breast ductal carcinoma in situ.
    Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
    Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.
    Olewniczak S; Chosia M; Kołodziej B; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
    Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
    Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between morphometrical parameters and disease-free survival in ductal breast cancer treated only by surgery.
    Tosi P; Luzi P; Sforza V; Santopietro R; Bindi M; Tucci E; Barbini P; Baak JP
    Appl Pathol; 1986; 4(1-2):33-42. PubMed ID: 3034310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast.
    Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S
    Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric analysis of differentiation in human breast carcinoma. Tumor heterogeneity.
    Sharkey FE
    Arch Pathol Lab Med; 1983 Aug; 107(8):411-4. PubMed ID: 6307212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.